NEW YORK (GenomeWeb) – Meridian Bioscience today announced its subsidiary Meridian Life Science has opened a new office in Beijing's central business district.
The firm said in a statement that it has established close relationships with major in vitro diagnostics companies in China by providing antigens, antibodies, and blockers for in vitro commercial assays.
"Our business in China is growing rapidly and we are committed to continue our investments in such an important market," Lourdes Weltzien, VP and General Manager of Meridian Life Science, said in a statement. She said that the new office demonstrates the firm's commitment to its Chinese customers and will help Meridian better service their needs.
Earlier this week, Raymond James Equity downgraded shares of Meridian Bioscience to Underperform and said that the firm may need to look to mergers and acquisitions to stimulate growth.